JNJ
Johnson & Johnson Reports Strong Q3 2026 Results: Accelerated Growth and Impact Ahead
Johnson & Johnson (JNJ) has reported a strong third quarter for 2026, with operational sales growth of 6% ahead of analyst consensus. This performance reinforces the company's confidence in meeting its guidance and exceeding $100 billion in annual revenue for the first time in its 140-year history. The